Abivax (AAVXF) Non-Current Assets (2022 - 2025)

Abivax has reported Non-Current Assets over the past 4 years, most recently at $38.5 million for Q4 2025.

  • Quarterly results put Non-Current Assets at $38.5 million for Q4 2025, up 4.33% from a year ago — trailing twelve months through Dec 2025 was $38.5 million (up 4.33% YoY), and the annual figure for FY2025 was $37.4 million, changed 0.03%.
  • Non-Current Assets for Q4 2025 was $38.5 million at Abivax, up from $36.9 million in the prior quarter.
  • Over the last five years, Non-Current Assets for AAVXF hit a ceiling of $44.2 million in Q4 2023 and a floor of $36.9 million in Q4 2024.
  • Median Non-Current Assets over the past 4 years was $39.3 million (2022), compared with a mean of $40.0 million.
  • Biggest five-year swings in Non-Current Assets: rose 10.09% in 2023 and later decreased 16.47% in 2024.
  • Abivax's Non-Current Assets stood at $40.2 million in 2022, then increased by 10.09% to $44.2 million in 2023, then fell by 16.47% to $36.9 million in 2024, then rose by 4.33% to $38.5 million in 2025.
  • The last three reported values for Non-Current Assets were $38.5 million (Q4 2025), $36.9 million (Q4 2024), and $44.2 million (Q4 2023) per Business Quant data.